KOSCIUSKO COUNTY — A woman who had a fracture repaired with a Zimmer manufactured part has filed a suit for damages against the Warsaw manufacturer. Carol Foreman, Macy, filed a complaint for damages Friday, Jan. 19, against Zimmer Biomet Holdings Inc., a Delaware Corporation, Indianapolis, with its principal place of business in Warsaw. She is …read more.

WARSAW — Zimmer Biomet Holdings Inc. announced it has successfully completed its offer to purchase all outstanding shares of the common stock of LDR Holding Corporation for $37 per share, net to the seller in cash, without interest, less any deductions or withholding of taxes required by applicable law. The tender offer expired at midnight, New …read more.

WARSAW — Zimmer Biomet Holdings Inc. reported today, Thursday, April 28, financial results for the quarter ended March 31. The company reported first-quarter net sales of $1.90 billion, an increase of 67.8 percent on a reported basis and an increase of 1.2 percent on an adjusted pro forma, constant currency basis, compared to the first …read more.

WARSAW — Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, announced today, Tuesday, April 26, it will participate in the Deutsche Bank Securities 41st annual Health Care Conference at the InterContinental Hotel, Boston, Mass., Thursday, May 5. Zimmer Biomet will present at 12:50 p.m. A live webcast of the presentation can be accessed …read more.

WARSAW — Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, has announced that it has secured an exclusive global distribution agreement with CelgenTek Innovations Corporation, which includes its N-Force Fixation System and iN3 Cement. This innovative bone void-filling solution allows healthcare professionals to directly administer Zimmer Biomet’s N-Force Blue­­­­­­-Bone Substitute Material and CelgenTek’s …read more.

WARSAW — Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, is pleased to announce that the company has received 510(k) clearance from the U.S. Food and Drug Administration for the compatibility of the Nexel Total Elbow System with the Comprehensive Segmental Revision System. This 510(k) clearance marks the first submission by the Company to …read more.

WARSAW — Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced the commercial launch of three new hip portfolio offerings, innovatively designed to address a broad range of clinical indications, patient anatomy and surgical techniques. These enhancements to three successful Zimmer Biomet Hip systems combine clinical heritage with new advances in implant design …read more.

WARSAW — Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, announced Wednesday, Feb. 24, its board of directors has approved payment of a quarterly cash dividend to stockholders for the first quarter, 2016. The new payment represents an increase of 9.1 percent over the dividend declared for the first quarter of 2015. Additionally, Zimmer Biomet’s …read more.

WARSAW — Zimmer Biomet Holdings Inc. announced certain of its stockholders, consisting of affiliates of Blackstone and Goldman Sachs, intend to offer for sale in an underwritten secondary offering 11,027,558 shares of the common stock of Zimmer Biomet Holdings Inc. The selling stockholders will receive all of the proceeds of the offering. Neither Zimmer Biomet …read more.

WARSAW — Zimmer Biomet Holdings Inc. reported financial results for the fourth quarter and full year ended Dec. 31, 2015. The company reported fourth-quarter net sales of $1.93 billion, an increase of 58.1 percent over the prior year period on a reported basis and an increase of 0.5 percent on an adjusted pro forma, constant …read more.

WARSAW — Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, announced it will participate in the 27th annual Piper Jaffray Healthcare Conference at the Lotte New York Palace Hotel in New York Tuesday, Dec. 1. Daniel Florin, chief financial officer of Zimmer Biomet, will present at 9 a.m. Eastern time. A live webcast …read more.

WARSAW — Zimmer Biomet Holdings Inc. reported Thursday, Oct. 29, financial results for the quarter ended Sept. 30. The Company reported third-quarter net sales of $1.76 billion, an increase of 59.3 percent, as reported. The increase in the quarter was 0.7 percent on an adjusted pro forma, constant currency basis over the same prior year period. Reported diluted earnings per share …read more.